SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 398 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,780,077 | +1045.1% | 28,830 | +1259.9% | 0.29% | +848.4% |
| Q2 2023 | $242,782 | -90.8% | 2,120 | -88.9% | 0.03% | -89.6% |
| Q1 2023 | $2,635,447 | -5.2% | 19,121 | -10.9% | 0.30% | -5.7% |
| Q4 2022 | $2,781,046 | +994.9% | 21,462 | +834.8% | 0.32% | +1028.6% |
| Q3 2022 | $254,000 | -71.1% | 2,296 | -80.4% | 0.03% | -67.8% |
| Q2 2022 | $878,000 | +28.4% | 11,716 | +33.9% | 0.09% | +19.2% |
| Q1 2022 | $684,000 | -23.0% | 8,751 | +68.0% | 0.07% | +10.6% |
| Q4 2020 | $888,000 | +120.3% | 5,210 | +81.5% | 0.07% | +153.8% |
| Q3 2020 | $403,000 | -75.9% | 2,870 | -72.5% | 0.03% | -82.9% |
| Q2 2020 | $1,671,000 | -82.9% | 10,423 | -92.0% | 0.15% | -72.2% |
| Q3 2019 | $9,788,000 | – | 129,950 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |